Previous 10 | Next 10 |
2023-12-08 07:22:17 ET Summary Quest Diagnostics is a global leader in diagnostic testing, information, and services, providing diverse products to a broad clientele. The company capitalized on COVID-19 testing to boost earnings. However, post-pandemic, the decline in revenues det...
UDX also announces the initial closing of its series B financing of approximately $70 million with investors, including Quest Diagnostics Financing to support UDX's pursuit of FDA premarket approval for its colorectal cancer screening blood test CAMBRIDGE, MA and SECAUCUS, NJ / ACCESSWIR...
Quest Diagnostics and CDC Expand Public Health Research Collaboration to Better Understand Hepatitis C Burden in the United States PR Newswire Quest will provide research consulting, laboratory testing and data analytics services to generate diagnostics insights supporting popul...
Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Seventh Consecutive Year PR Newswire SECAUCUS, N.J. , Dec. 6, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diag...
NORTHAMPTON, MA / ACCESSWIRE / December 5, 2023 / Quest Diagnostics Originally published in Quest Diagnostics Corporate Responsibility Report 2022 2025/2026 Goals Expand our electric vehicle pilot project to include 3 additional lab locations by 2025 Secure ISO 14001 certification for 3...
NORTHAMPTON, MA / ACCESSWIRE / November 28, 2023 / Quest volunteers recently served lunch to children and families battling pediatric cancer and other serious illnesses at Ronald McDonald House New York, in collaboration with Quest for Health Equity (Q4HE) and Sesame Workshop. "On behalf of our...
Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis PR Newswire Relationship leverages Quest's sequencing and specimen collection expertise with Scipher's precision medicine technology SECAUCUS, N.J...
NORTHAMPTON, MA / ACCESSWIRE / November 27, 2023 / Quest Diagnostics Originally published in Quest Diagnostics Corporate Responsibility Report 2022 2022 highlights: Contributed ~$15 million in corporate giving and Q4HE grants Provided ~750,000 donated or discounted test requisitions, a...
NORTHAMPTON, MA / ACCESSWIRE / November 21, 2023 / Quest Diagnostics Originally published in Quest Diagnostics Corporate Responsibility Report 2022 We aim to deliver empathetic, high-quality, and convenient individualized care. Strengthening our approach to patient-centered care Develop...
Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States PR Newswire UDX also announces the initial closing of its series B financing of approximately $70 mil...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR Newswire BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRN...
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-24 07:00:10 ET Eric Coldwell from Robert W. Baird issued a price target of $154.00 for DGX on 2024-07-24 06:36:00. The adjusted price target was set to $154.00. At the time of the announcement, DGX was trading at $140.96. The overall price target consensus is at ...